Devine, P. J., Ekert, J., Kopec, A. K., Stresser, D. M., Ramsden, D., Szilagyi, J., Hewitt, P., Hardwick, R. N., Laing, S., Van Vleet, T. R., Moalli, M., & Bajaj, P. (2025). Pharmaceutical industry perspective on the utility of animal cell-based microphysiological systems to support human drug development. ALTEX, 10.14573/altex.2407122.

Stresser, D. M., Kopec, A. K., Hewitt, P., Hardwick, R. N., Van Vleet, T. R., Mahalingaiah, P. K. S., ... & Homan, K. A. (2023). Towards in vitro models for reducing or replacing the use of animals in drug testing. Nature Biomedical Engineering, 1-6.   

Ewart, L., Fabre, K., Chakilam, A., Dragan, Y., Duignan, D. B., Eswaraka, J., Gan, J., Guzzie-Peck, P., Otieno, M., Jeong, C. G., Keller, D. A., de Morais, S. M., Phillips, J. A., Proctor, W., Sura, R., Van Vleet, T., Watson, D., Will, Y., Tagle, D., & Berridge, B. (2017). Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective. Experimental biology and medicine (Maywood, N.J.), 242(16), 1579–1585.